DENTSPLY SIRONA (XRAY) Issues FY 2018 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY 2018 earnings guidance on Thursday. The company provided EPS guidance of $2.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.08.

A number of brokerages recently issued reports on XRAY. ValuEngine raised DENTSPLY SIRONA from a strong sell rating to a sell rating in a research note on Wednesday, October 24th. Goldman Sachs Group raised DENTSPLY SIRONA from a sell rating to a buy rating and set a $44.00 price target for the company in a research note on Friday, October 19th. BidaskClub lowered DENTSPLY SIRONA from a hold rating to a sell rating in a research note on Thursday, September 27th. HC Wainwright set a $40.00 price target on DENTSPLY SIRONA and gave the stock a hold rating in a research note on Friday, August 31st. Finally, TheStreet lowered DENTSPLY SIRONA from a c- rating to a d+ rating in a research note on Tuesday, August 14th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company. DENTSPLY SIRONA has a consensus rating of Hold and an average price target of $51.50.

XRAY traded up $0.29 during trading on Thursday, hitting $36.80. 3,963,454 shares of the stock were exchanged, compared to its average volume of 2,693,468. The company has a market capitalization of $7.90 billion, a P/E ratio of 13.83, a PEG ratio of 2.06 and a beta of 1.15. DENTSPLY SIRONA has a 1 year low of $33.93 and a 1 year high of $68.98. The company has a quick ratio of 1.10, a current ratio of 1.69 and a debt-to-equity ratio of 0.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, topping the consensus estimate of $0.59 by $0.01. The company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.03 billion. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. During the same period last year, the business posted $0.65 EPS. Equities analysts anticipate that DENTSPLY SIRONA will post 2.07 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by WKRB News and is owned by of WKRB News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.wkrb13.com/2018/11/09/dentsply-sirona-xray-issues-fy-2018-earnings-guidance.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: Short Selling Stocks, A Beginner’s Guide

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply